Grace Therapeutics's total assets for Q2 2026 were C$66.58M, a decrease of -4.63% from the previous quarter. GRCE total liabilities were C$3.76M for the fiscal quarter, a -39.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.